Local Institution - 0103

Cluj-Napoca 400352

1 studies enrolling now · 2 studies all time

What they study most

Advanced Cancer, Advanced Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) — Recruiting now
• An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer — Completed